BlockBeats News, June 3rd, Longevity tech startup NewLimit, co-founded by Coinbase co-founder Brian Armstrong, announced the completion of a $435 million Series C funding round, valuing the company at $3.1 billion. The round was led by Peter Thiel's Founders Fund, with continued participation from Abstract Ventures, Kleiner Perkins, NFDG, Eli Lilly Ventures, Valor Equity Partners, and introduced new investors including Thrive Capital, Greenoaks, and Quiet Capital. In 2021, Brian Armstrong, together with former GV partner and bioengineer Blake Byers, and stem cell biologist Jacob Kimmel, invested $110 million to establish NewLimit in the southern part of San Francisco.